RONZI, PAOLA
RONZI, PAOLA
Dipartimento di Scienze Biomediche e Cliniche
Unconventional T cells in chronic hepatitis B patients on long-term suppressive therapy with tenofovir followed by a Peg-IFN add-on strategy: A randomized study
2018 E.S. Cannizzo, C. Tincati, F. Binda, P. Ronzi, F.A. Cazzaniga, S. Antinori, A. d'Arminio Monforte, G. Marchetti, L. Milazzo, E.S. Cannizzo
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting
2017 L. Milazzo, C. Gervasoni, F.S. Falvella, D. Cattaneo, C. Mazzali, P. Ronzi, F. Binda, S. Cheli, S. Sollima, S. Antinori
Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders
2015 L. Milazzo, D. Cattaneo, E. Calvi, C. Gervasoni, C. Mazzali, P. Ronzi, A.M. Peri, A.L. Ridolfo, A. D'Avolio, S. Antinori
Stable changes in CD4+ T-lymphocyte microRNA expression following exposure to HIV-1
2012 F. Bignami, E. Pilotti, L. Bertoncelli, P. Ronzi, M. Gulli, N. Marmiroli, G. Magnani, M. Pinti, L. Lopalco, C. Mussini, R. Ruotolo, M. Galli, A. Cossarizza, C. Casoli
Temporal regulation of HTLV-2 expression in infected cell lines and patients : evidence for distinct expression kinetics of different transcripts with nuclear accumulation of APH-2 mRNA
2012 C. Bender, F. Rende, A. Cotena, P. Righi, P. Ronzi, I. Cavallari, C. Casoli, V. Ciminale, U. Bertazzoni
IDENTIFICAZIONE DI TRE NUOVI PEPTIDI SALIVARI BASICI RICCHI DI PROLINA CARATTERIZZATI DA ATTIVITÀ ANTI- HIV-1
2012 P. Ronzi
Analysis of temporal expression of HTLV-2 reveals similarities and functional differences from HTLV-1
2011 C. Bender, A. Cotena, P. Ronzi, F. Rende, I. Cavallari, C. Casoli, V. Ciminale, U. Bertazzoni
miRNAs used by HTLV-2 as strategic weapons to prevent HIV-1 replication
2011 E. Pilotti, P. Ronzi, F. Bignami, M. Gulli, N. Marmiroli, G. Magnani, M. Galli, L. Lopalco, C. Mussini, R. Ruotolo, A. Cossarizza, C. Casoli
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk
2011 L. Polonelli, L. Giovati, W. Magliani, S. Conti, S. Sforza, A. Calabretta, C. Casoli, P. Ronzi, E. Grilli, A. Gallo, F. Masoero, G. Piva
Changes in CD4+ cells miRNA expression following exposure to HIV-1
2010 F. Bignami, E. Pilotti, L. Bertoncelli, P. Ronzi, M. Gulli, N. Marmiroli, G. Magnani, M. Pinti, C. Mussini, L. Lopalco, R. Ruotolo, M. Galli, A. Cossarizza, C. Casoli
Complex pattern of HTLV-2 splicing and expression in PBMCs from infected patients
2010 C. Bender, A. Cotena, P. Ronzi, F. Rende, V. Ciminale, C. Casoli, U. Bertazzoni
Striking changes of miRNAs expression in peripheral CD4+ T lymphocytes from HIV-1 infected and HIV-1 exposed uninfected people
2010 F. Bignami, E. Pilotti, L. Bertoncelli, P. Ronzi, M. Gulli, N. Marmiroli, G. Magnani, M. Pinti, L. Lopalco, C. Mussini, M. Galli, A. Cossarizza, C. Casoli
Striking changes of miRNAs expression in CD4+ T lymphocytes occurred even in the absence of an established HIV-1 infection
2010 F. Bignami, E. Pilotti, L. Bertoncelli, P. Ronzi, M. Gulli, N. Marmiroli, G. Magnani, L. Lopalco, R. Ruotolo, M. Galli, A. Cossarizza, C. Casoli
Complex pattern of HTLV-2 temporal expression in infected cell lines and patient PBMCs and identification of a novel splicing acceptor site
2010 C. Bender, A. Cotena, P. Ronzi, F. Rende, I. Cavallari, V. Ciminale, C. Casoli, U. Bertazzoni
Changes in CD4+ cells’ miRNA expression following exposure to HIV-1
2010 F. Bignami, E. Pilotti, L. Bertoncelli, P. Ronzi, M. Gulli, N. Marmiroli, G. Magnani, M. Pinti, C. Mussini, L. Lopalco, R. Ruotolo, M. Galli, A. Cossarizza, C. Casoli
Kinetic analysis of Human T-cell Leukemia Virus type 2 expression in chronically-infected cells and patient PBMCs
2009 C. Bender, P. Righi, F. Rende, P. Ronzi, C. Casoli, V. Criminale, U. Bertazzoni
Kinetics of human-T cell leukemia virus type 2 (HTLV-2) mRNA expression in PBMCs isolated from infected subjects
2009 C. Bender, P. Ronzi, F. Rende, A. Cotena, M. Turci, I. Cavalleri, V. Ciminale, C. Casoli, U. Bertazzoni
Time course of Human-T cell Leukemia Virus type 2 (HTLV-2) gene expression in PBMCs from infected patients
2009 C. Bender, P. Ronzi, F. Rende, A. Cotena, M. Turci, V. Ciminale, C. Casoli, U. Bertazzoni
Analysis of viral transcripts of Human T-cell Leukemia Virus type 2 (HTLV-2) in human T- and B- infected cells and PBMCs from infected subjects
2008 P. Righi, C. Bender, F. Rende, C. Casoli, P. Ronzi, V. Criminale, U. Bertazzoni
Antibody Complementary-Determining Regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities
2008 L. Polonelli, J. Pontón, N. Elguezabal, María D. Moragues, C. Casoli, E. Pilotti, P. Ronzi, A.S. Dobroff, E.G. Rodrigues, M.A. Juliano, D.L. Maffei, W. Magliani, S. Conti, L.R. Travassos